Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Chinese Herbal Medicine Nasal Irrigation for Allergic Rhinitis
NCT05901532Phase 2Completed
- Sponsor
- Taichung Veterans General Hospital
- Start
- Nov 2020
- Primary completion
- Apr 2022
- Modality
- Covalent Small Molecules, Classical Binding Small Molecules, Nucleic Acid-Directed Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of chuanxiong, magnolia biondii flower bud, scutellariae radix, borneol in allergic rhinitis (AR), sponsored by Taichung Veterans General Hospital. Started Nov 2020; status: completed.
02
Drugs
chuanxiongmagnolia biondii flower budscutellariae radixborneol
03
Conditions
allergic rhinitis (AR)
Beyond the preview
Go deeper on NCT05901532.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05901532.